Vaccines to be offered to teenagers aged 15 to 18 in India from New Year

Both doses of the vaccine have been given to more than 60 per cent of the population in India eligible for the corona vaccine.

At a time when the new variant of the Corona, Omikro, is gaining traction around the world, all countries are working to stop its transition. Under such circumstances, it is imperative that citizens living in different countries be fully vaccinated. According to research on Omicron, although this variant is not lethal, the infection spreads rapidly, in which case vaccination of children is essential to prevent its transmission to children.

80 million teenagers benefit

Prime Minister Narendra Modi addressing the nation on Saturday night said that people between the ages of 15 and 18 will be vaccinated against corona from January 3. This will benefit 80 million teenagers between the ages of 15 and 18 in the country. In addition, from January 10, all front line workers, including health workers, will be given a 'Precaution Dose'.

The Drug Controller General of India (DGCI) has approved for emergency use the Covid-19 vaccine for children manufactured by Bharat Biotech. With the approval of DGCI, Bharat Biotech vaccine can now be given to 12 to 18 year olds. However, a decision on the use of this vaccine for young children is still pending. So let's take a look at the vaccinations of children all over the world so far ...

More than 100 countries around the world are currently vaccinating children against corana

A report has been prepared by UNICEF by studying the 115 million cases of Corana reported in 105 countries of the world. According to the report, only 16 percent of corona cases are responsible for coronary heart disease. Apart from this most of the children who suffer from corona infection do not show any symptoms of corona. Three pediatric vaccines are currently approved by the World Health Organization (WHO). These vaccines include the Pfizer-Biotech vaccine, the Synopharm vaccine and the Synovac vaccine. Some countries offer two full doses of the Pfizer-Biotech vaccine to children and adults. While some countries offer a single dose of the vaccine. According to the London School of Hygiene and Tropical Medicine, clinical trials of 20 vaccines for individuals under the age of 18 are currently underway.

In May, the European Medicines Agency approved Pfizer's vaccine for children aged 12-15. However, since then there have been differences of opinion in various European countries.

United Kingdom (UK): United Kingdom which is not currently part of the European Union. It has approved a single dose of Pfizer-Biotech vaccine for children aged 12 to 15 years.

Denmark and Spain: Denmark (12 to 15 years old) and Spain (12 to 19 years old) have vaccinated most children in the country. All of these children have been given a single dose of the vaccine.

Italy: Italy approves vaccine for children aged 5-11 on December 1.

Czech Republic: The Czech Republic has ordered vaccines for 700,000 children. It will be given to 5-11 year olds.

Hungary: Since May, Hungary has started vaccinating 16 to 18 year olds.

Russia: Russia will make the new vaccine available to children aged 12-17 by the end of December.

Switzerland: Switzerland approved Pfizer vaccine for children aged 12 to 15 in June. The modern vaccine for children of the same age was later approved two months later.

France: France has given a single dose of the vaccine to 66 per cent of children aged 12 to 17 living in the country. Both doses of the vaccine have been given to 52% of the same age group.

Germany: In June, German experts said that only children between the ages of 12 and 15 who are in poor health should be vaccinated. The transition to the Delta variant, however, accelerated much later in August. The vaccine was administered to all those over 12 years of age.

Sweden: Only children between the ages of 12 and 15 who have lung disease were vaccinated in Sweden. Apart from this, children who have lung, asthma or serious health problems were also allowed to be vaccinated.

Norway: Norway is not part of the European Union. It has recently been decided to vaccinate children between the ages of 12 and 15. However, children of this age are given only the first dose. The decision on whether to give a second dose will be made later.

United States and Canada

In May, the United States and Canada approved the Pfizer vaccine for children 12 years of age and older. Immediately after that the children were vaccinated. As part of this, children of this age were given two doses of the vaccine within three weeks.

By the end of July, 42 percent of children between the ages of 12 and 17 had received the first dose of the Pfizer or Mordana vaccine. While 32% also took a second dose of Pfizer or Modern. The growing number of cases of delta variants in the United States has accelerated the drive to vaccinate children in the country.

According to a recent report by the Center for Disease Control, in states where vaccination was low, the incidence of coronary heart disease was 3.4 to 3.7 times higher. Some school boards have made vaccination compulsory for children over the age of 12, in favor of starting classes.

Pfizer has begun testing its vaccine on young children. As part of this, data on testing of children aged 5 to 11 came in September. Data on trials for children aged 6 months to 4 years are expected by the end of the year.

Bahrain: Bahrain has approved synoform vaccine for children aged 3-11 years.

Israel, Oman and Saudi Arabia: Israel, Oman and Saudi Arabia have approved Pfizer vaccine for children. It can be given to children up to 5 years. The vaccine has been approved for emergency use in Bahrain and the United Arab Emirates for the same age.

Jordan, Morocco, Guinea, Nabia, South Africa: These countries have approved vaccination for children 12 years of age and older.

Zimbabwe: Zimbabwe has approved vaccinations for children 14 years of age and older.

Egypt: Egypt said in November that it would start vaccinating children aged 15-18 with the Pfizer vaccine.

China: China approves synoform and synovac vaccines for pediatric vaccination. The vaccine can also be given to a three-year-old child.

Hong Kong: A three-year-old child living in Hong Kong can be vaccinated. In November alone, the synovic vaccine was given to three-year-olds.

SINGAPORE: The age limit for vaccination of children in Singapore is likely to be reduced to 5-11 years from next January. A decision on the age limit in Japan is expected in February. While Malaysia is currently planning to buy vaccines for children of this age.

INDONESIA: Indonesia has approved sonovac vaccine for children over the age of six.

India: India allows Zydus Cadillac vaccine for emergency use in children over 12 years of age. So on December 25, the Drug Controller General of India (DGCI) approved the Covid-19 vaccine for children, developed by Bharat Biotech, for emergency use. With the approval of DGCI, Bharat Biotech vaccine can now be given to 12 to 18 year olds. However, a decision on the use of the vaccine for young children is yet to be made.

South Korea, Philippines, Philippines: These countries are vaccinating children 12 years of age and older. However, Australia will start vaccinating young children from January. Children will be vaccinated against Pfizer in Australia from 10 January.

Vietnam: Vietnam has started vaccinating children aged 16 and 17 from October.

Cuba: A 2-year-old child can be vaccinated in Cuba. The country's target is to vaccinate 90 per cent of the population by the end of December.

Venezuela: Venezuela said in November that it was vaccinating a 2- to 11-year-old child with the Cuban Sobre 2 vaccine.

Argentina: A three-year-old child can also be vaccinated in Argentina. Here children are given synoform vaccine for vaccination.

Click here to read news report

Brazil: In June, Brazil approved the Pfizer vaccine for 12-year-old children. However, Brazil's health regulator said in October that its directors had received death threats for approving vaccinations for children under the age of five.

Colombia: Colombia has approved Pfizer, AstraZeneca, Moderna, Cinopharm and Johnson & Johnson vaccines for vaccinating children 12 and older.

Ecuador: In Ecuador, children 6 years of age or older can be vaccinated. Synovac vaccine is used for this.